Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Canaccord Genuity Maintains Buy on Monday.Com, Raises Price Target to $330

Canaccord Genuity analyst David Hynes maintains Monday.Com (NASDAQ:MNDY) with a Buy and raises the price target from $275 to $330.

byBenzinga Newsdesk

August 18, 2021

1 minute read

Canaccord Genuity analyst David Hynes maintains Monday.Com (NASDAQ:MNDY) with a Buy and raises the price target from $275 to $330.

Pfizer/BioNTech’s COVID-19 Vaccine Mere 12% Effective In Kids 5-11 Years, New York Study Shows

By Vandana Singh

Today, 2:23 PM

According to a published study, Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) two-dose COVID-19 vaccine provided very little protection for children aged 5 to 11 years during the wave of o

BNTX

Goldman Sachs Initiates Coverage On CGI with Sell Rating

By Benzinga Newsdesk

Today, 2:23 PM

Goldman Sachs analyst Brian Essex initiates coverage on CGI (NYSE:GIB) with a Sell rating.

GIB

News

Read How Spirit Airlines Performed In Peak Summer Schedule

By Akanksha Bakshi

Today, 2:23 PM

Spirit Airlines Inc's (NYSE: SAVE) operational performance ranked among the industry best in the two-month period following the peak summer schedule.

SAVE

Jefferies Initiates Coverage On SpringBig Holdings with Buy Rating, Announces Price Target of $4.5

By Benzinga Newsdesk

Today, 2:23 PM

Jefferies analyst Owen Bennett initiates coverage on SpringBig Holdings (NASDAQ:SBIG) with a Buy rating and announces Price Target of $4.5.

SBIG

Canaccord Genuity Maintains Buy on Monday.Com, Raises Price Target to $330

Related Posts

Pfizer/BioNTech’s COVID-19 Vaccine Mere 12% Effective In Kids 5-11 Years, New York Study Shows

Goldman Sachs Initiates Coverage On CGI with Sell Rating

Read How Spirit Airlines Performed In Peak Summer Schedule

Jefferies Initiates Coverage On SpringBig Holdings with Buy Rating, Announces Price Target of $4.5